Terns Pharmaceuticals (TERN) Q4 2025 Earnings

10NovConfirmed
Q1 2025
Q2 2025
Q3 2025
Q4 2025
-0.31
-0.28
-0.26
-0.24

Details

Expected EPS
-0.294282
Actual EPS
-0.27
Surprise EPS
0.02
Surprise Percent
+8.25%

Description

Terns Pharmaceuticals (TERN) has reported earnings of -0.27 per share for Q4 2025.

0 Comments

Share your thoughts